C-DQNFBloom Science
live biotherapeutics, gut-brain axis, ketogenic biology
modulatingmicrobiome therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-DQNF
C-DQNFC-DQNFlive biotherapeutics, gut-brain axis, ketogenic biology
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Bloom Science live biotherapeutics, gut-brain axis, ketogenic biology
Bloom Science is a clinical-stage biotechnology company developing next-generation live biotherapeutic medicines targeting the gut-brain axis. Its lead program, BL-001, is an oral once-daily live biotherapeutic designed to reverse-engineer ketogenic biology into a scalable medicine. The company is advancing BL-001 in obesity and Developmental & Epileptic Encephalopathies, including Dravet syndrome.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Bloom Science — Translational · Bottom quartile. Derived deterministically from 7 extracted project(s). Most-advanced status: phase 1. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic